학술논문
Erratum: Ropivacaine, the N-propyl homologue of bupivacaine [available only as the pure S-(-)-enantiomer], has only recently been introduced for use on children, but the results of preliminary studies suggest that it will probably have a predominant place in paediatrics (CNS Drugs (November 1999) 12:5 (357-368))
Document Type
Erratum
Author
Source
In: CNS Drugs . (CNS Drugs, 2000, 13(1):76)
Subject
Language
English
ISSN
11727047